Moreover, OV90 ovarian cancer cells exposed to carboplatin plus paclitaxel for 24 h failed to manifest increased CALR exposure on the plasma membrane, at odds with OV90 cancer cells exposed to idarubicin (an anthracycline that triggers ICD) (Additional file 1: Figure S5D). Here, CALR is linked to ovarian carcinoma.